Health ❯ Medical Research

Drug Development

Clinical Trials Disease Modeling Targeted Therapy AI in Healthcare Therapeutics DNA-Encoded Chemical Libraries Protein Structure Prediction Vaccines Disease Treatment Cancer Research Viral Inactivation Protein-Based Therapies Protein-based Drugs Synthetic Proteins Therapeutic Design Antibiotics Molecular Biology Anti-Aging Treatments Chemical Reactions Breakthroughs Therapeutic Options Aduhelm Efficacy Therapeutic Response Vaccine Research Regulatory Approval Life-saving Drugs Structural Biology Oncology Clinical Guidelines Photopharmacology Protein Interactions AI in Medicine Antiparasitic Drugs Vaccine Targets Antiviral Drugs Inflammatory Diseases Protein Targets FDA Regulations Targeted Therapies Monoclonal Antibodies Combination Therapy Clinical Testing Protein Biology Cancer Treatment Biotechnology

Bristol Myers Squibb Buys Orbital Therapeutics for $1.5 Billion to Push In Vivo CAR‑T Into Autoimmune Care

The deal signals a pivot toward in‑body cell reprogramming for autoimmune disease.